Cardiac and respiratory                real-time data of clinical quality in a small and wearable strip

RDS (Rhythm Diagnostic Systems) is a medical device company aiming at bringing to market the first miniaturized and connected wearable medical strip for real-time monitoring of several key cardiac and respiratory parameters. Our Franco-American team is based in Strasbourg (France) and in Palo Alto (California, USA), and has a extensive experience in medical electronics, digital health, and cutting edge innovation. Members of the team have worked in successful startups as well as large technology companies.

Objet dynamique vectoriel1

Member of the large-scale program “Tomorrow’s Health Initiative” (piloted by Strasbourg Eurometropole, more info in French here ).


Incubated at SEMIA, recognised as an Excellency Incubator of the Grand Est region


Laureate of the I-Lab award by the Ministry of Research and Innovation

Our Product

The MultiSense® strip is a unique solution combining technology, simplicity and lightness and is protected by 5 families of patents in Europe, North America and Asia.

With 5 embedded sensors, MultiSense® is the only wearable and connected device able to continuously measure 11 vital sign parameters including heart rate, respiratory rate, and oxygen saturation, with clinical grade quality. The MultiSense® strip is very light weight, easy to wear, water-resistant with a unique proprietary adhesive layer, and has 7 days battery life.

MultiSense® is currently in the advanced prototype stage, has already been tested extensively with healthy volunteers, and is currently being tested with patients. We are particularly aiming at post-surgical patient monitoring, and actively exploring other key clinical needs, including diagnostics.

Our Values

RDS aims at having a positive impact on society through improving patient diagnostic, monitoring and well-being. We are an enthusiastic and highly dedicated team that participates in the e-Health revolution, by delivering continuous high-quality vital signs’ monitoring while enabling patients to be monitored in a less constrained environment, such as home.

The impact will thus be positive for society as a whole with significant improvement of healthcare systems, a more secure patient’s journey, and improved clinical outcomes. In addition, our solution will also enable affordable and easy-to perform diagnostics and patient monitoring in countries with less developed healthcare systems.

Our Team

Our enthusiastic and multidisciplinary team already covers many key skill areas and is growing. The overall team combines a good balance between strongly experienced people and highly qualified and motivated graduates. We are based in Strasbourg (France) and in Palo Alto (California, USA).


 Our main offices are in the heart of Strasbourg, capital of Europe, in one of the most prominent and advanced European University Hospitals.

French Team

US Team

Our Strategic Committee

We benefit from a recognized and highly experienced strategic committee :

Elie has 20 years of successful management experience in digital health. Elie has been involved in the creation of two previous digital health start-ups, has directed teams in the public and the private sector, and has been the CEO of Orange Healthcare (a subsidiary of Orange Business Services dedicated to e-health). He is an Engineer from Ecole Centrale Paris (France) and from Cornell University (USA), holds a PhD in Neuroimaging, and has also studied Medicine at Pitie-Salpetriere Hospital in Paris. Elie is the CEO of RDS SAS since its incorporation at the beginning of 2020.

Michel RONC Photo

Michel has 30 years of experience as an investor and has as an extensive and successful track record of major investment decisions in the fields of Energy and Health, in Europe and the US. He is the cofounder of Demeter Investment Fund and has been a board member of several risk capital funds including Sofinnova. Michel is a key player in the development of a strong startup ecosystem in the Grand Est region of France. Michel is an Engineer from Toulouse (France), holds a PhD from McGill University (Canada), and has studied management at Harvard Business School (USA).


Sam has 40 years of experience as manager and investor. As a serial entrepreneur, he has been the founder of several major successes such as Applied Biosystems, Lynx Therapeutics, Compass Genetics and Andrew Alliance. He is an Engineer from Grenoble (France), holds a PhD in Biophysics from the University of California in Berkeley (USA), and collaborated for many years with Sidney Brenner who was awarded the Nobel Prize in Physiology and Medicine in 2002.

Jeff has 30 years of experience in medical, biotech, and consumer electronics. Jeff received a BSEE from Cornell University (USA) and an MBA from Stanford’s Graduate School of Business (USA). Out of college, he started with Hewlett Packard as a manufacturing engineer, and then joined Sam Eletr at Applied Biosystems as an electronics design engineer. Jeff later worked at Sony Corporation, working in Tokyo (Japan) in international business development for the first Electronic Book project.

Sophie has an MEng and aPhD in Biotechnology at UTC Compiègne, and also holds a HEC MBA. She is a medtech entrepreneur, and has previously been General Manager of Livanova France & UK, CCO of Mauna Kea technologies and CEO of Cellnovo. She now is a partner at Agile Capital Markets.

Piero has a Master and PhD in Physics from Ferrara University. He started his career as a scientist at CERN, and then became CSO SpinX Technologies, and later CEO of Andrew Alliance until its successful acquisition by Waters in 2020. He authored or contributed to more than 100 publications, and is now involved as a business angel in several startups including RDS.


Christian has a PhD in Biochemistry and is a co-founder of RDS. He worked previously at Sanofi as executive VP for diagnostic, agro-veterinary and capital development, and then at Institut Pasteur as executive VP technology transfer. He was also chairman of Cellectis. He now seats at the boards of several life science companies (including RDS) and charities.

Our Clinical Advisory Board

We benefit from a recognized and highly experienced clinical advisory Board :

Pr Marescaux is a digestive surgeon and university professor. He was the head of the department of digestive surgery at Strasbourg University Hospital. He is the founding director of IRCAD and also founded IHU Strasbourg. He also founded IRCAD Taiwan, Brazil, Africa. He authored or contributed to more than 300 scientific publications.

Pr Mutter is digestive surgeon and university professor. He is the current  head of the department of digestive surgery at Strasbourg University Hospital. He also teaches at IRCAD and IHU Strasbourg, and is a fellow of the American College of Surgeons.  He authored or contributed to more than 200 scientific publications.


Pr Bethoux is a general surgeon and university professor. He headed a department of surgery at Paris University Hospital and is now very involved in the development of patient hotels as an way of improving surgical patients pathways. He authored or contributed to more than 40 scientific publications.

Our Partners

RDS and our project benefit from the essential support of several key institutions and stakeholders :

with the support of Pr Jacques Marescaux

Contact us

Please contact us for any question regarding our product or company.

Work in Progress. MultiSense® is not currently in distribution.

  Copyright ©2020. RDS SAS. All Rights Reserved.